Skip to content
Oxymorphone
Numorphan, Opana (oxymorphone) is a small molecule pharmaceutical. Oxymorphone was first approved as Opana on 1982-01-01. It is used to treat pain in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oxymorphone hydrochloride
Tradename
Company
Number
Date
Products
OPANAEndoN-011707 DISCN1982-01-01
2 products, RLD
NUMORPHANEndoN-011738 DISCN1982-01-01
1 products
OPANA EREndoN-021610 DISCN2006-06-22
7 products, RLD
OPANAEndoN-021611 DISCN2006-06-22
2 products, RLD
OPANA EREndoN-201655 DISCN2011-12-09
7 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
opanaNew Drug Application2012-01-13
oxymorphone hydrochlorideANDA2023-04-13
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
painEFO_0003843D010146R52
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Oxymorphone Hydrochloride, Opana Er, Endo Pharms
88717792029-11-22DP
78514822029-07-10DP
88087372027-06-21U-1598, U-3085
81927222025-09-15DP
81143832024-08-08DP
80758722023-11-20DP
83090602023-11-20DP
72762502023-02-04DPU-826
83091122023-02-04DP
83091222023-02-04DP
83292162023-02-04DP
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02A: Opioid analgesics
— N02AA: Natural opium alkaloid analgesics
— N02AA11: Oxymorphone
HCPCS
Code
Description
J2410
Injection, oxymorphone hcl, up to 1 mg
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOXYMORPHONE
INNoxymorphone
Description
Oxymorphone is a morphinane alkaloid.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5
Identifiers
PDB—
CAS-ID76-41-5
RxCUI7814
ChEMBL IDCHEMBL963
ChEBI ID7865
PubChem CID5284604
DrugBankDB01192
UNII ID9VXA968E0C (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Oxymorphone - Amneal Pharmaceuticals
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 2,557 documents
View more details
Safety
Black-box Warning
Black-box warning for: Oxymorphone hydrochloride
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
77 adverse events reported
View more details